Steven Moore, DPM
Podiatrist · Peoria, AZNPI 1306101571
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 108 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Musculoskeletal Transplant Foundation Inc. at 24.7% of the total. Reporting peaked in 2020 at $906 and has fallen 74.8% since, to $228 in 2025.
Across 108 payments — averaging $25.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Musculoskeletal Transplant Foundation Inc.$676
- Melinta Therapeutics, LLC$411
- Stryker$267
- Bioventus LLC$157
- Smith+Nephew$153
- Amgen$149
- plus $921 from 19 others
What the payments were for
- Food & beverage$2,734100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Musculoskeletal Transplant Foundation Inc. | 6 | $676 |
| Melinta Therapeutics, LLC | 32 | $411 |
| Stryker(2 entities) | 6 | $267 |
| Bioventus LLC | 10 | $157 |
| Smith+Nephew | 6 | $153 |
| Amgen(2 entities) | 8 | $149 |
| Biowound Solutions, Inc. | 2 | $120 |
| Johnson & Johnson | 5 | $117 |
| AbbVie | 4 | $79 |
| Nevro Corp. | 4 | $74 |
| Zyla Life Sciences, Inc. | 4 | $58 |
| Integra Lifesciences Corporation | 3 | $56 |
| Zimmer Biomet | 1 | $52 |
| Acell, Inc. | 3 | $50 |
| Surgenex LLC | 2 | $50 |
| Orthofix Medical, Inc. | 3 | $47 |
| DJO, LLC | 1 | $44 |
| Forthright Medical - AZ, LLC | 1 | $41 |
| Organogenesis Inc. | 1 | $38 |
| Nalu Medical, Inc. | 1 | $21 |
| Celularity Inc. | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Osiris Therapeutics Inc. | 1 | $14 |
| Advanced Oxygen Therapy Inc. | 1 | $12 |
| Medtronic | 1 | $12 |
How this compares
$2,734 in reported general payments places this provider in the 75th percentile of 151 podiatrist providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Terbinafine Hcl | 94 | $1,935 |
| Clindamycin Hcl | 35 | $1,041 |
| Doxycycline Monohydrate | 62 | $799 |
| Gabapentin | 82 | $583 |
| Ciclopirox | 20 | $334 |
| Methylprednisolone | 26 | $230 |
| Furosemide | 21 | $147 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $120 |
| Ibuprofen | 13 | $94 |
| Tramadol Hcl | 18 | $69 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Peoria
- Chad WestphalPeoria$300K
- Samuel StrothmanPeoria$14K
- Keith BangartPeoria$5K
- Daniel BangartPeoria$4K
- David BatesPeoria$1K
- Dylan KaumayaPeoria$1K
- Kris DinucciScottsdale$1.4M
- Lewis FreedMesa$997K
- Stephen KominskySun City West$508K
- Kerry ZangMesa$111K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.